NCT02404207

Soybean Oil Trial of cArdiovascular Risk

The Effect of High-Oleic Soybean Oil on Biomarkers of Risk for Metabolic Syndrome

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: USDA Beltsville Human Nutrition Research Center · Federal
• Sex: All
• Age: 30 Years – 70 Years
• Healthy volunteers: Accepted

Summary

The study will determine the effects of different types of soybean oils on biomarkers of risk for cardiovascular disease and diabetes. There will be four 4-week diet periods in which participants will consume the following oils, within the context of a controlled diet: soybean oil, high-oleic soybean oil, blend of high oleic soybean oil \& fully hydrogenated soybean oil, and blend of palm olein \& palm stearin.

Conditions

• Cardiovascular Disease
• Diabetes
• Metabolic Syndrome

Interventions

Type	Name	Description
OTHER	Soybean oil	Participants will be fed soybean oil as part of a controlled (typical American) diet.
OTHER	High-oleic soybean oil	Participants will be fed high-oleic soybean oil as part of a controlled (typical American) diet.
OTHER	High-oleic soybean oil + fully hydrogenated soybean oil	Participants will be fed a blend of high-oleic soybean oil and fully hydrogenated soybean oil as part of a controlled (typical American) diet.
OTHER	Palm olein + palm stearin	Participants will be fed a blend of palm olein + palm stearin as part of a controlled (typical American) diet.

Timeline

• Start date: 2015-03-01
• Primary completion: 2015-10-01
• Completion: 2015-10-01
• First posted: 2015-03-31
• Last updated: 2016-05-12

Locations

1 site across 1 country: United States